about
High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regionsHeterogeneous nuclear ribonucleoprotein P2 is an autoantibody target in mice deficient for Mer, Axl, and Tyro3 receptor tyrosine kinasesComplement in age-related macular degeneration: a focus on functionSystemic lupus erythematosus and the type I interferon systemCytokines in systemic lupus erythematosus, London, UKEarly Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune DiseasesArylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discoveryPentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors.Predicting and preventing autoimmunity, myth or reality?Infections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyDistinctive clinical features of pediatric systemic lupus erythematosus in three different age classes.Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndromeOveractivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.Surface complement C3 fragments and cellular binding of microparticles in patients with SLECopy number variants in genetic susceptibility and severity of systemic lupus erythematosusGenetic factors predisposing to systemic lupus erythematosus and lupus nephritis.Monocyte Expressed Macromolecular C1 and C1q Receptors as Molecular Sensors of Danger: Implications in SLEErythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.Fragment Bb: evidence for activation of the alternative pathway of the complement system in pregnant women with acute pyelonephritis.Immunopathology and the gene therapy of lupus.Anti-C1q antibodies as a follow-up marker in SLE patientsMacrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells.The candidate gene approach: have murine models informed the study of human SLE?Inhibition of terminal complement: a novel therapeutic approach for the treatment of systemic lupus erythematosus.Could antibodies to C-reactive protein link inflammation and cardiovascular disease in patients with systemic lupus erythematosus?Genetics of lupus nephritis.Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus.Ocular manifestations of systemic lupus erythematosus: a review of the literatureReno-protective effect and mechanism study of Huang Lian Jie Du Decoction on lupus nephritis MRL/lpr miceNonbilayer Phospholipid Arrangements Are Toll-Like Receptor-2/6 and TLR-4 Agonists and Trigger Inflammation in a Mouse Model Resembling Human Lupus.Lack of immunoglobulins does not prevent C1q binding to RGC and does not alter the progression of experimental glaucoma.Familial clustering of systemic lupus erythematosus in the cayman islands.Cigarette smoking and systemic lupus erythematosus: a smoking gun?Internalization of rituximab and the efficiency of B Cell depletion in rheumatoid arthritis and systemic lupus erythematosusVitamin d deficiency in patients with systemic lupus erythematosus.Activation of the alternative pathway of complement is a feature of pre-term parturition but not of spontaneous labor at termFragment Bb in amniotic fluid: evidence for complement activation by the alternative pathway in women with intra-amniotic infection/inflammationRare variants, autoimmune disease, and arthritisImmune and inflammatory role in renal disease.Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus.
P2860
Q21092448-DA62DD5C-7BD5-48D3-92BB-5D342822C94CQ24299348-E77C8F19-2E2C-4741-AB20-D5A9E4B7748EQ24635874-45C9AA90-6E1B-41DE-B383-B4C9E7AEF675Q24804235-304AAE94-AC6C-4304-A761-70D7E4759100Q24804899-A6CEDA6E-1FB7-44F7-92FD-956F1413828DQ26766486-ACB57A46-763F-4D6B-B5B0-9C7800D7674DQ26995125-D5293CD0-5CFB-4DDE-9646-B9D980EA6D3CQ27687176-970C9F45-532C-4D9A-906E-2D0B6971F076Q28199608-AB74A086-4633-44F8-A6DD-97F3B85ACFA1Q28972389-DD2BDED4-2346-413E-8B12-04A8077641DAQ33376311-1FFA1B04-460C-49BA-A2EC-DC6A8933F14BQ33402827-DD6770B1-DD9B-4CDF-B364-43BC3F1A6B44Q33423118-33C05652-834D-4018-B849-7917EB75D7E3Q33552712-936EA1F2-75EA-40A8-B415-D8F046B319C8Q33680420-F720E2C0-93EB-485C-8B75-B54AACA149E6Q33761431-88FB3C7F-8488-4958-BC95-933D42C94630Q33808073-DA7BD769-EDE4-4C3D-A498-08058CDBE90CQ34051962-D1F3CF46-E332-4630-8EC5-2212BC940C09Q34139940-8D18B68B-4BBD-421B-A8AD-68DB3429B18EQ35122166-63584CF2-2862-4906-882A-B76AEEBD3DDDQ35448756-D434324B-6D2E-4D0E-9384-5AC68A09685EQ35636696-FFBB748B-ADB4-4C7E-A94A-B5567ECA2830Q35804473-CA15EDA6-B392-4D69-A770-664FB0F440D0Q35824482-3ABDDB99-EB9F-4D6E-B9E5-A52058E7B355Q35953555-9D0052AC-257B-4D3B-8451-6CE27C95715CQ36054813-106CBC3F-7B04-4F45-A4A6-3FF1242E8D25Q36065912-F35CAD41-B0F5-48E4-A677-0B631E6F55F1Q36091026-6E7D24CE-4B55-4D53-AAE1-A620AB141D1DQ36186103-1BF38787-D651-4FAA-AF37-AF1F90E12107Q36237416-746B7A73-00FB-4AD9-B64C-D1DCAF8D4DE8Q36299887-61E2E4BF-B318-485A-AB6F-43D4B7330BADQ36330826-C24F976E-4A76-47E7-B2F2-2B4506C0FC31Q36350811-DFD3A930-3CBB-4529-A189-1165D5740475Q36532571-4F9064CE-BCB6-436C-B3F7-BDD8640F318AQ36583806-6E3EC6DA-AD63-4F69-A559-5E08B58688FDQ36714154-10491C63-D8A0-46C5-BFCA-E489AD983B3EQ36720470-210DFB61-1733-4CF6-A765-AD38DD113CD0Q37012282-BDAEA2BC-E08D-4C67-BCE3-AEC848A27FECQ37243199-8944B903-94B7-42B1-B25C-6FC6D5F85D88Q37270846-2E196A99-E2F8-42CF-9ADB-9DD5C7AE870A
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Complement and systemic lupus erythematosus.
@ast
Complement and systemic lupus erythematosus.
@en
Complement and systemic lupus erythematosus.
@nl
type
label
Complement and systemic lupus erythematosus.
@ast
Complement and systemic lupus erythematosus.
@en
Complement and systemic lupus erythematosus.
@nl
prefLabel
Complement and systemic lupus erythematosus.
@ast
Complement and systemic lupus erythematosus.
@en
Complement and systemic lupus erythematosus.
@nl
P2860
P356
P1476
Complement and systemic lupus erythematosus.
@en
P2860
P2888
P304
P356
10.1186/AR586
P433
P478
P50
P577
2002-05-09T00:00:00Z
P5875
P6179
1019698738